EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Rare Cancer Explorer 1.0 (RaCE 1.0): a dedicated database and analytical platform focused on rare cancers

Yihao Chen iD, Le Zhang, Chuanfan Zhong, Songbo Li, Ruidong Li iD, Zhenyu Jia iD, Peisheng Huang, Shuo Wang, Zitao He, Huawei Lin, Xiaowen Lin, Kai Chen und 7 weitere

Nucleic Acids Research · 06.01.2026 · 54 (D1) · D1590-D1607

DOI: 10.1093/nar/gkaf911 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 24.09.2025. Verfasst von Yihao Chen und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Andrology, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, Guangdong 510180, Ch…. Hauptthemen laut MEDLINE: Neoplasms, Rare Diseases, Databases, Genetic, Software. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, Young Scientists Fund of the National Natural Science Foundation of China, Science and Technology Development Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rare cancers face major research challenges due to limited sample sizes and data scarcity. Existing pan-cancer databases mainly focus on common cancer types, while rare cancers often lack sufficient attention and systematic data collection. In addition, their high heterogeneity and the scarcity of studies on genomic features, immune environments, and drug responses lead to significant gaps in current databases and analytical tools. To address these limitations, we developed the Rare Cancer Explorer (RaCE), a dedicated database for integrated curation, analysis, and visualization of rare cancers. RaCE consolidates 5451 samples spanning 13 rare solid tumor types from 69 independent datasets, offering researchers a one-stop data analysis toolkit. The database provides one integrated dataset meta-analysis module and eight dedicated rare cancer functional analysis modules, including transcriptomics, immune infiltration, and immunotherapy response prediction, with a specialized focus on modeling gene effects and drug sensitivity in rare cancer cell lines. RaCE distinguishes itself through robust interactive functionalities, enabling users to seamlessly explore multi-layered insights from gene functions to therapeutic targets, thereby accelerating precision medicine and translational research for rare cancers. Compared to existing databases, RaCE demonstrates unique advantages in supporting rare cancer research through comprehensive data integration. The database is freely accessible at https://biospace.shinyapps.io/race/ or https://hiplot.com.cn/race/.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsRare DiseasesDatabases, GeneticSoftwareHumansImmunotherapyPrecision Medicine

Autor:innen und Institutionen

  • Department of Andrology, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, Guangdong 510180, China.
  • Genetics, Genomics, and Bioinformatics Program, University of California, Riverside, CA 92521, United States.
  • Department of Urology, Guangdong Key Laboratory of Clinical Molecular Medicine and Diagnostics, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou,Guangdong 510180, China.
  • Department of Urology, Nanxishan Hospital of Guangxi Zhuang Autonomous Region, The Second People's Hospital of Guangxi Zhuang Autonomous Region, Guilin 541002, China.
  • Department of Botany and Plant Sciences, University of California, Riverside, CA 92521, United States.
  • Department of Urology, Huizhou Central People's Hospital, Huizhou, Guangdong 516001, China.

ORCID-Profile: Yihao Chen, Ruidong Li, Zhenyu Jia, Jianming Lu

Förderung

  • National Natural Science Foundation of China
  • Young Scientists Fund of the National Natural Science Foundation of China
  • Science and Technology Development Fund
  • Guangdong Provincial Natural Science Foundation
  • Regional Joint Fund - Regional Cultivation Project
  • Regional Joint Fund – Regional Cultivation Project

Zitieren

APA

Chen, Y., Zhang, L., Zhong, C., Li, S., Li, R., Jia, Z., Huang, P., Wang, S., He, Z., Lin, H., Lin, X., Chen, K., Huang, Z., Mo, S., Cai, Z., Deng, J., Zhong, W., Chen, J., & Lu, J. (2026). Rare Cancer Explorer 1.0 (RaCE 1.0): a dedicated database and analytical platform focused on rare cancers. Nucleic Acids Research, 54(D1), D1590-D1607. https://doi.org/10.1093/nar/gkaf911

Vancouver

Chen Y, Zhang L, Zhong C, Li S, Li R, Jia Z, et al. Rare Cancer Explorer 1.0 (RaCE 1.0): a dedicated database and analytical platform focused on rare cancers. Nucleic Acids Research. 2026;54(D1):D1590-D1607. doi:10.1093/nar/gkaf911

BibTeX
@article{Chen2026,
  author = {Chen, Yihao and Zhang, Le and Zhong, Chuanfan and Li, Songbo and Li, Ruidong and Jia, Zhenyu and Huang, Peisheng and Wang, Shuo and He, Zitao and Lin, Huawei and Lin, Xiaowen and Chen, Kai and Huang, Zhuoya and Mo, Shanshan and Cai, Zhouda and Deng, Junhong and Zhong, Weide and Chen, Jiahong and Lu, Jianming},
  title = {Rare Cancer Explorer 1.0 (RaCE 1.0): a dedicated database and analytical platform focused on rare cancers},
  journal = {Nucleic Acids Research},
  year = {2026},
  volume = {54},
  number = {D1},
  pages = {D1590--D1607},
  doi = {10.1093/nar/gkaf911}
}
Kostenlos starten →